EVEROLIMUS

49683 reported adverse events

Drug classes: Kinase Inhibitor [EPC] mTOR Inhibitor Immunosuppressant [EPC]

These side effects are most commonly reported by patients taking EVEROLIMUS:

# Side effect Count
0 DEATH 6304
1 MALIGNANT NEOPLASM PROGRESSION 4591
2 DIARRHOEA 3999
3 FATIGUE 3745
4 STOMATITIS 3153
5 NAUSEA 2784
6 DYSPNOEA 2613
7 DRUG INEFFECTIVE 2293
8 PYREXIA 2110
9 VOMITING 2092
See all common reactions for EVEROLIMUS

EVEROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 96 0.4138
1 ANGIOFIBROMA 26 0.3514
2 PANCREATIC NEUROENDOCRINE TUMOUR 167 0.2738
3 BRAIN STEM GLIOMA 32 0.2270
4 PIK3CA-ACTIVATED MUTATION 68 0.2173
5 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 42 0.1826
6 POLYOMAVIRUS VIRAEMIA 171 0.1823
7 NEUROENDOCRINE TUMOUR 229 0.1684
8 INSULINOMA 26 0.1529
9 BLOOD CHROMOGRANIN A INCREASED 62 0.1435
See all enriched reactions for EVEROLIMUS